Henry Schein (NASDAQ:HSIC) reported a 7.7% increase in fourth-quarter net sales, reaching $3.4 billion as the company benefited from a rebound in high-margin dental equipment and specialty product demand.
The growth was led by the company’s Global Specialty Products segment, which jumped 14.6% year-over-year, driven by strong performance in dental implants and endodontics.
The Global Dental Distribution unit also showed significant momentum, with equipment sales rising 12.2%.
Management highlighted particularly strong equipment demand in the U.S., Germany, Brazil, Canada, and Australia.
GAAP net income for the quarter rose to $101 million, or $0.85 per diluted share, up from $94 million in the prior-year period.
On an adjusted basis, net income reached $160 million, or $1.34 per share, surpassing the $1.19 reported in the fourth quarter of 2024.
Adjusted EBITDA grew to $291 million, up from $270 million a year ago.
While dental segments provided the bulk of the growth, the company's Global Technology unit saw an 8.4% increase in sales.
This was underpinned by the "accelerated adoption" of cloud-based practice management software and the rollout of new digital solutions.
The Global Medical division also reported a more modest 4.9% increase.
While underlying medical product sales remained healthy, the company noted continued softness in the respiratory category as post-pandemic demand patterns fully stabilize.